Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1178 | 1127 | 1137 | 830 | 1190 | 2145 |
Fund Return | 17.83% | 12.67% | 13.72% | -6.01% | 3.54% | 7.93% |
Place in category | 50 | 456 | 70 | 42 | 186 | 22 |
% in Category | 8 | 66 | 11 | 11 | 71 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RT SZSE 100 Index Fund A\B | 4.7B | 12.64 | -10.47 | 5.51 | ||
RT Domestic Consumption Driven Fund | 3.53B | 6.44 | 6.18 | 14.56 | ||
Rongtong Healthy Indus Flexible All | 3.04B | -17.95 | -3.39 | - | ||
Rongtong China style No.1 Alloc | 1.63B | 1.07 | -15.96 | - | ||
Rongtong Growth 30 Flxbl Alloc Fd | 1.61B | 7.29 | 7.55 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhong Ou Modern Pioneer InitiatingA | 13.27B | 9.61 | -11.66 | - | ||
TianHong ChiNext Index A | 9.62B | 14.29 | -12.30 | - | ||
TianHong ChiNext Index C | 9.62B | 14.10 | -12.47 | - | ||
ICBC Credit Literary Ids Eq | 5.94B | 13.82 | -7.77 | - | ||
Harvest Emerging Industry Eq | 5.63B | -0.61 | -14.83 | 11.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Kweichow Moutai | CNE0000018R8 | 7.38 | 1,509.00 | +0.70% | |
Amperex Tech A | CNE100003662 | 4.05 | 256.72 | -2.79% | |
China Merchants Bank | CNE000001B33 | 3.60 | 36.39 | +0.47% | |
Ping An Insurance | CNE000001R84 | 3.60 | 53.05 | +0.91% | |
China Yangtze Power | CNE000001G87 | 3.14 | 27.00 | -0.48% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Buy | BUY |
Summary | Strong Sell | Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review